CClinicalTrials.gg
Not yet recruitingNCT07854834REFILL-ITUpdated Oct 2, 2026

Simulation-Based Intrathecal Pump Refill Training

An interventional study of Simulation-based intrathecal pump refill training in Intrathecal Drug Delivery, sponsored by Universitair Ziekenhuis Brussel. Not yet recruiting at 1 site in Belgium. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by Universitair Ziekenhuis Brussel · Not applicable, Interventional, and Supportive care

Updated Oct 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Intrathecal drug delivery is an effective treatment option for patients with chronic (non-) cancer pain or spasticity who do not achieve sufficient benefit from conventional therapies. After intrathecal pump implantation, intrathecal pump refilling is an essential postoperative maintenance procedure that requires procedural competence to be performed safely and consistently. Despite the absence of a standardized intrathecal pump refill protocol, the REFFIL-IT study aims to train 40 participants in intrathecal pump refilling. Based on the learning curve during simulation-based training and the number of complete simulated refill procedures required to achieve stable procedural competence, a step-by-step standardized intrathecal pump refill protocol will be developed. The REFILL-IT study aims to contribute to the safe and correct intrathecal pump refilling in patients with chronic (non-) cancer pain and spasticity.

02

Conditions studied

  • Intrathecal Drug Delivery

Keywords

  • Intrathecal drug delivery
  • Pump refill
  • Learning curve
  • Simulation-based
  • Neuromodulation
03

In context

Lead sponsor

Universitair Ziekenhuis Brussel is the lead sponsor of 362 studies on the registry; 103 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthcare professionals
  • (Healthcare) students;
  • Aged ≥18 years;
  • No prior independent performance of intrathecal pump refill procedures;
  • Dutch speaking.

Exclusion criteria

Exclusion Criteria:

  • Visual impairments preventing participation in stimulated-based intrathecal pump training;
  • Conditions such as severe neurological or musculoskeletal disorders affecting hand function that preclude participation in the training.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Simulation-based intrathecal pump refill training

    Procedure: Simulation-based intrathecal pump refill training

Interventions

  • ProcedureSimulation-based intrathecal pump refill training

    The REFILL-IT study consists of two mandatory phases and an optional third clinical phase. During the Knowledge Acquisition Phase, participants will receive theoretical and practical instruction through educational videos and a written step-by-step guide. Progression requires successful completion of a knowledge assessment covering the refill procedure. In the Skill Development Phase, participants will repeatedly perform simulated intrathecal pump refill procedures using explanted SynchroMed II™ (Medtronic) dummy pumps positioned beneath a 15-mm silicone skin pad. Each procedure will be assessed as either successful or unsuccessful to evaluate the development of procedural competence. Participants who achieve stable competence and are physicians legally authorized to perform intrathecal pump refills in Belgium may progress to the Clinical Application Phase, where they will perform refill procedures in patients under the direct supervision of an experienced healthcare professional.

06

What researchers measure

Primary outcomes

  1. Number of complete simulated intrathecal pump refill procedures required to achieve stable procedural competence

    The number of complete simulated intrathecal pump refill procedures required to achieve stable procedural competence will be determined using Learning Curve Cumulative Sum (LC-CUSUM) analysis.

    Time frame: Immediately after the intervention, namely after the simulated intrathecal pump refill procedures during the Skill Development Phase and during the Clinical Application Phase

Secondary outcomes

  1. Total Objective Structured Assessment of Technical Skills (OSATS) score per simulated refill procedure

    Each (simulated) refill procedure will be evaluated using an OSATS-based assessment tool, assessing four predefined domains: aseptic technique, correct port access, volume verification, and procedural safety.

    Time frame: Immediately after the intervention, namely after the simulated intrathecal pump refill procedures during the Skill Development Phase and during the Clinical Application Phase

  2. Attempt-level success or failure

    Each (simulated) refill procedure will be classified as successful or failed based on the OSATS score and the occurrence of critical procedural errors.

    Time frame: Immediately after the intervention, namely after the simulated intrathecal pump refill procedures during the Skill Development Phase and during the Clinical Application Phase

  3. Number and type of critical procedural errors

    The number and type of critical procedural errors occurring during each simulated refill procedure will be recorded.

    Time frame: Immediately after the intervention, namely after the simulated intrathecal pump refill procedures during the Skill Development Phase and during the Clinical Application Phase

  4. Number and type of procedural errors

    Non-critical procedural errors, including minor deviations, delays, and technical difficulties, will be recorded during each (simulated) refill procedure.

    Time frame: Immediately after the intervention, namely after the simulated intrathecal pump refill procedures during the Skill Development Phase and during the Clinical Application Phase

  5. Proportion of participants achieving stable procedural competence within the predefined training phase

    The number of participants achieving stable procedural competence according to the predefined LC-CUSUM decision rule will be recorded, or until a maximum of 16 complete simulated refill procedures has been reached.

    Time frame: Immediately after the intervention, namely after the simulated intrathecal pump refill procedures during the Skill Development Phase and during the Clinical Application Phase

  6. Number of participants requiring additional supervised practice or remediation after the predefined training phase

    The number of participants requiring additional supervised practice or remediation will be recorded.

    Time frame: Immediately after the intervention, namely after the simulated intrathecal pump refill procedures during the Skill Development Phase and during the Clinical Application Phase

  7. Number of port-access attempts per simulated refill procedure

    The number of port-access attempts per (simulated) refill procedure will be recorded, with a maximum of three attempts per procedure.

    Time frame: Immediately after the intervention, namely after the simulated intrathecal pump refill procedures during the Skill Development Phase and during the Clinical Application Phase

  8. Total procedure time of a complete simulated refill procedure

    The total time required to complete each (simulated) intrathecal pump refill procedure will be recorded.

    Time frame: Immediately after the intervention, namely after the simulated intrathecal pump refill procedures during the Skill Development Phase and during the Clinical Application Phase

  9. Time required for individual procedural steps

    The time required for individual procedural steps during a (simulated) intrathecal pump refill procedure will be recorded.

    Time frame: Immediately after the intervention, namely after the simulated intrathecal pump refill procedures during the Skill Development Phase and during the Clinical Application Phase

07

Study locations

1 site
  • UZ Brussel/VUB
    Jette, 1090, Belgium
    • Maarten Moens · Contact · stimulusresearchgroup@gmail.com · +3224775514
    • Ulrike Van Hoey, MSc · Sub investigator
    • Maarten Moens, MD, PhD, MBA · Principal investigator
    • Britt Winnepenninckx, MSc · Sub investigator
    • Lisa Goudman, MSc, PhD, MBA · Sub investigator
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07854834
Lead sponsor
Universitair Ziekenhuis Brussel
Responsible party
Sponsor
First posted
Oct 2, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Oct 1, 2028 (estimated)
Completion
Oct 1, 2028 (estimated)
Last update
Oct 2, 2026

Study contacts

Maarten Moens, MD PhD MBA
Contact
stimulusresearchgroup@gmail.com
+3224775514
Lisa Goudman, MSC, PhD, MBA
Contact
lisa.goudman@vub.be

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion